Election 2019: T1D research remains a winner
JDRF would like to congratulate all those MPs that were elected in the 2019 Federal Election. We would like to congratulate the Morrison Liberal National Coalition for their return to Government and wish them well into the future.
Given the partisan nature of Australian politics, with two major parties, there is an inherent challenge for any advocacy group or charity. This is, which side of politics are more likely to support you? At JDRF we have remained rigorously bi-partisan in our approach to politics. This means that we ensure to maintain our relationships both sides of the political aisle. We work extremely hard to ensure regardless of party allegiance or faction, all of Australia’s federal politicians understand the realities of living with T1D and why research holds the key.
It is down to this hard work that we went into the election knowing both major parties knew about the impact of the CRN and why its continuation was key to the 120,000 Australians living with T1D. So much so in fact, that in January the Morrison government confirmed over $50m for T1D research, including $25m for the CRN.
And while it is outstanding that the work of the CRN can continue, our work with government does not stop there. Over the coming months, we’ll be working with the community, researchers and advocates to ensure we keep raising awareness with decision makers in Canberra of the issues facing people living with T1D.
And finally, some of our youngest advocates, and aspiring artists, have written their own thanks, which you can check out below.
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, led […]
New research funding may allow those with type 1 diabetes to make insulin again
JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.
JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Changes to the Federal Government’s Insulin Pump Program
The Australian Government’s Insulin Pump Program (IPP), administered by JDRF Australia, provides insulin pumps to young Australians up to the age of 21, living with type 1 diabetes (T1D), who meet certain financial and clinical eligibility requirements. The program supplies fully subsidised insulin pumps to people who would otherwise be unable to access insulin pump […]